Kennedy Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.9M | Buy |
|
|||||
|
2025
Q2 | $21.9M | Sell |
|
|||||
|
2025
Q1 | $25.7M | Buy |
|
|||||
|
2024
Q4 | $21.2M | Sell |
|
|||||
|
2024
Q3 | $20.7M | Sell |
|
|||||
|
2024
Q2 | $19.8M | Buy |
|
|||||
|
2024
Q1 | $16.9M | Buy |
|
|||||
|
2023
Q4 | $8.87M | Sell |
|
|||||
|
2023
Q3 | $7.44M | Buy |
|
|||||
|
2023
Q2 | $4.07M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $5.1M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $3.94M | Sell |
|
|||||
|
2018
Q2 | $3.29M | Buy |
|
|||||
|
2018
Q1 | $1.95M | Sell |
|
|||||
|
2017
Q4 | $3.48M | Sell |
|
|||||
|
2017
Q3 | $2.27M | Sell |
|
|||||
|
2017
Q2 | $2.54M | Buy |
|
|||||
|
2017
Q1 | $449K | Sell |
|
|||||
|
2016
Q4 | $245K | Sell |
|
|||||
|
2016
Q3 | $265K | Sell |
|
|||||
|
2016
Q2 | $176K | Buy |
|
|||||
|
2016
Q1 | $286K | Sell |
|
|||||
|
2015
Q4 | $608K | Sell |
|
|||||
|
2015
Q3 | $747K | Buy |
|